Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

Share Price is delayed by 15 minutes
Get Live Data
2.20    0.45 (25.71%)
Bid:
2.10
Ask:
2.30
Spread: 0.20 (9.524%)
Market Cap: £3.01m
IGE Live PriceLast checked at - London Stock Exchange

Intraday Image Scan Holdings Share Chart

AGM Statement

25 Feb 2026 07:00

RNS Number : 2287U
Image Scan Holdings PLC
25 February 2026
 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

25 February 2026

 

 IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

AGM Statement

 

Trading in the early part of FY26 has been significantly ahead of the same period last year, supported by several notable contract wins already announced. As a result, the Company now expects to record a small loss at the half-year, reflecting stronger demand and an increased volume of activity across multiple markets compared with H1 last year.

Market activity levels are considerably higher than at the same time last year, with the sales team engaged across a wider range of tenders, demonstrations, and partner-led opportunities. Our channel network continues to strengthen and the introduction of the ThreatScan‑AS2, along with enhancements to the ThreatScan- AS1, has broadened our competitive positioning in higher specification tenders.

The announcement earlier this month of the termination for convenience of the large UK defence programme subcontracted to Image Scan via NP Aerospace was clearly disappointing.It is important to note that the decision was not performance related and did not arise from any failing by Image Scan or NP Aerospace. We remain in discussions to reach an orderly conclusion to the termination process.

Although the defence programme had been expected to contribute materially to FY27 and FY28 revenues, the Company has entered FY26 with a strong order book, containing a number of our latest portable system, the ThreatScan-AS2.

In the industrial business, the anticipated decline in catalyst-related capital equipment sales has been partially offset by the successful introduction of a new software module giving enhanced inspection capability to the existing installed equipment across the globe. Recurring service and support contracts continue to provide a stable revenue stream and mitigate the reduced demand for new industrial systems.

Despite the removal of the large defence contract, as at 31 January 2026 the Company had a strong order book of £1.1 m (FY25 adj £0.7m) which contains a number of our latest portable system, the ThreatScan-AS2. In addition as at 31 January 2026, the Company retains a solid cash position £1.1 m (FY25 £0.7m), reflecting disciplined management and continued demand for both security and industrial solutions and services.

The Company remains focused on accelerating growth through:

· continued expansion of the ThreatScan portfolio, particularly AS2;

· increasing sales reach through our global partner network;

· introducing additional complementary products, either internally developed or factored; and

· advancing opportunities for strategic partnerships, aligned with our technical capabilities and international footprint.

Vincent Deery, Chief Executive Officer of Image Scan, commented: "We have had a much stronger start to the year compared with the same period last year, with several key contract wins and increased activity across all major markets. While the termination of the UK defence programme is disappointing, it was not performance-related, and we continue to progress discussions around its orderly conclusion.

Our strengthened order book, promising sales momentum, and continued innovation, particularly with the ThreatScan‑AS2, give us confidence as we move into the second half of the year."

 

For further information on the Company, please visit: www.ish.co.uk and for further information on its products, please visit: www.3dx-ray.com

 

-ENDS-

 

Image Scan Holdings plc Tel: +44 (0) 1509 817400

Vincent Deery CEO

Sarah Atwell-King, CFO & Company Secretary

 

 

Zeus - Nominated Advisor and Corporate Broker Tel: +44 (0)203 829 5000

Mike Coe/James Bavister (Investment Banking)

 

ABOUT IMAGE SCAN HOLDINGS PLC

About Image Scan Holdings plc

The core activity of the Group is the manufacture of portable X-ray systems for security and counter terrorism applications. The Group recently launched a cabinet X-ray machine and is replacing its Axis range of checkpoint X-ray systems with new machines developed with a partner. All these products are taken to market across the world through a strong network of international partners.

 

In addition, over the last seventeen years, Image Scan has developed and manufactured industrial X-ray inspection systems, the MDXi range. The primary market for these systems is in automotive emissions control where they are used for quality control inspection of catalytic converters and diesel particulate filters.

 

The visibility and reach of the Company's 3DX-Ray brand has been further strengthened through a new LinkedIn profile focussed on its EOD and counter-terrorism activities. This can be found at: https://www.linkedin.com/company/3dx-ray/

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMAKQBBABKDQBB
Date   Source Headline
14th Jun 20073:06 pmRNSEGM Statement
21st May 200712:22 pmRNSChange of Adviser
21st May 200712:18 pmRNSShare Placing/Trading update
21st May 200712:10 pmRNSInterim Results
20th Apr 200710:05 amRNSDirector/PDMR Shareholding
23rd Mar 200712:00 pmRNSResult of AGM
27th Feb 20077:01 amRNSHolding(s) in Company
15th Jan 20077:00 amRNSFinal Results
21st Dec 20067:00 amRNSHolding(s) in Company
14th Dec 20067:01 amRNSHolding(s) in Company
12th Dec 20068:00 amRNSTotal Voting Rights
14th Nov 20067:01 amRNSTrading Statement
13th Dec 20057:00 amPRNFinal Results
1st Nov 200512:00 pmPRNDate of Preliminary Results
1st Nov 200512:00 pmPRNDate of Preliminary Results
21st Oct 20056:00 amPRNNew Rapiscan Agreement
3rd Oct 20059:00 amPRNIssue of Options
13th Sep 20056:00 amPRNRe Contract
12th Aug 20056:30 amPRNRe Contract
29th Jul 20054:44 pmPRNDirectorate Change
5th Jul 20052:30 pmRNSSAR 5 - Image Scan-Replacemnt
1st Jul 200512:20 pmRNSSAR 5 - Image Scan Holdings
3rd Jun 20059:40 amPRNHolding(s) in Company
1st Jun 20056:30 amPRNInterim Results
31st May 20059:39 amPRNDirectorate Change
17th May 200510:15 amRNSLicensing Agreement
27th Apr 20052:29 pmRNSDirectors Shareholding
26th Apr 20052:15 pmRNSPlacing and Open Offer
26th Apr 20057:00 amRNSAGM and EGM Statement
31st Mar 20059:15 amRNSImage Scan Announces Placing
21st Mar 20058:45 amRNSDirector Declaration
8th Mar 200511:22 amRNSRe Contract
16th Feb 20058:45 amRNSProduct Launch
31st Jan 20054:39 pmRNSDirectorate Change
27th Jan 20055:12 pmRNSFinal Results
7th Jan 200510:39 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.